Risorse esterne
Opinione della community
Prezzo Variazione Volume
0.0405 0 €
P/E Obiettivo ad 1anno
0 2 €

Compra - Vendi

Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Altri utenti che hanno investito

Transations in last week
Buy: 21
Sell : 5

Simone Bonzanini david686



Echo Therapeutics (ECTE) Given News Impact Rating of 0.04 - The Ledger Gazette

Shares of Echo Therapeutics (NASDAQ ECTE) remained flat at $0.04 during trading on Friday. 40 shares of the stock were exchanged. Echo Therapeutics has a 1-year low of $0.04 and a 1-year high of $0.85. The stock's 50-day moving average is $0.04 and ...altro » Leggi

Echo Therapeutics Inc (ECTE): Following the Indicators - Baldwin Journal

Traders might be following the signals on shares of Echo Therapeutics Inc (ECTE). After a recent look, we can see that the SuperTrend line is now below the current stock price. This signal may alert traders that the stock has possibly entered into sell ... Leggi

Echo Therapeutics (ECTE) Earns News Sentiment Score of 0.05 - The Ledger Gazette

... press coverage is somewhat unlikely to have an impact on the company's share price in the next several days. Shares of Echo Therapeutics (NASDAQ ECTE) remained flat at $0.04 during mid-day trading on Monday. 1,050 shares of the stock traded hands.altro » Leggi


Penny stock shareholders are becoming inquisitive about ECHO THERAPEUTICS INCORPORATED (OTCMKTS:ECTE), following the fact that the share price has moved $0.0039, reaching the $0.14 price level in a recent trade. A big benefit of investing in ...altro » Leggi

This Weeks Target Prices For Echo Therapeutics, Inc. (ECTE) - NewsDen

The share price of the company (ECTE) was up +0.00% during the last trading session, with a high of 0.00 and the volume of Echo Therapeutics, Inc. shares traded was 0. Echo Therapeutics, Inc. is a medical device company. The Company is engaged in ... Leggi

Echo Street Capital Management Raised Its Grace WR & Co Del New (GRA) Position; 5 Analysts Covering CymaBay ... - High Point Observer

About 738,984 shares traded or 9.20% up from the average. CymaBay Therapeutics Inc (NASDAQ:CBAY) has risen 69.26% since September 17, 2016 and is uptrending. It has outperformed by 52.56% the S&P500. Among 12 analysts covering W. R. Grace ...altro » Leggi

Global Blood Therapeutics (GBT) Now Covered By Oppenheimer with $53.0 Target; Echo Street Capital Management ... - Key Gazette

The Echo Street Capital Management Llc holds 69,597 shares with $8.11 million value, down from 88,409 last quarter. Ps Business Pks Inc Calif now has $3.69B valuation. The stock rose 0.41% or $0.56 reaching $135.64. About 13,803 shares traded.altro » Leggi

MaxLinear, Inc. (MXL) Will Demonstrate Its Full Duplex DOCSIS (FDX) Technology- TG Therapeutics, Inc. (TGTX) - Investing News Update

... moved up 1.42% to the trading price of $23.54 in latest session. MaxLinear, Inc. (NYSE:MXL) reported that it will demonstrate its Full Duplex DOCSIS (FDX) technology showcasing MaxLinear's proprietary echo cancellation technology at the IBC Exhibition. Leggi

Echo Street Capital Management Trimmed Groupe Cgi (GIB) Holding; Corbus Pharmaceuticals Holdings (CRBP ... - High Point Observer

The Echo Street Capital Management Llc holds 76,000 shares with $3.65M value, down from 373,428 last quarter. Groupe Cgi Inc now has $13.64 billion valuation. The stock rose 0.19% or $0.1 reaching $51.94. About 73,623 shares traded. CGI Group Inc (NYSE ...altro » Leggi

Manchester Management LLC Reports: NEW YORK FEDERAL ... - PR Newswire (press release)

NEW YORK, Dec. 6, 2016 /PRNewswire/ -- On November 29, 2016, Manchester Management LLC and its affiliates (the "Plaintiffs) filed a complaint in Federal ...altro » Leggi